Results 341 to 350 of about 3,954,159 (357)

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

Ca-A Cancer Journal for Clinicians, 2014
Giada Bianchi, Kenneth C Anderson
exaly  

Phosphodiesterase inhibitors

2018
openaire   +1 more source

ACE INHIBITORS

The Lancet, 1988
openaire   +2 more sources

Synthetic inhibitors - PARP inhibitors

2020
openaire   +1 more source

TRYPSIN INHIBITORS

The Lancet, 1970
openaire   +2 more sources

GSK3 inhibitors: development and therapeutic potential

Nature Reviews Drug Discovery, 2004
Philip Cohen, Michel Goedert
exaly  

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh   +2 more
exaly  

Renin Inhibitors

2006
S H, Rosenberg, H D, Kleinert
openaire   +2 more sources

Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells

Nature Reviews Drug Discovery, 2009
Liqing Wang, Edwin F De Zoeten, Wayne W Hancock   +2 more
exaly  

Farnesyltransferase inhibitors

Update on Cancer Therapeutics, 2003
openaire   +5 more sources